• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

Global Measles, Mumps and Rubella (MMR) Vaccines Market Research Report 2020

report cover
  • 29 October 2020
  • Healthcare
  • 121 Pages
  • Report Code: 24LS-21735
  • Formate :   
Download FREE Report Sample Download PDF File

Measles Mumps Rubella Vaccines -MARKET ADVISORY SERVICES

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type, the Measles, Mumps and Rubella (MMR) Vaccines market is segmented into
Monovalent Vaccine
Polyvalent Vaccine

Segment by Application
Immune Center
Vaccine Development Agencies and Organizations
Hospital
Laboratory
Biotechnology and Biopharmaceutical Companies

Global Measles, Mumps and Rubella (MMR) Vaccines Market: Regional Analysis
The Measles, Mumps and Rubella (MMR) Vaccines market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Measles, Mumps and Rubella (MMR) Vaccines market report are:
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

Global Measles, Mumps and Rubella (MMR) Vaccines Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

The major players in global Measles, Mumps and Rubella (MMR) Vaccines market include:
Medlmmune
Johnson & Johnson
Merck
Sanofi
Serum
Bavarian Nordic
Astellas Pharma
Emergent BioSolutions
GlaxoSmithKline
Pfizer
CSL
1 Measles, Mumps and Rubella (MMR) Vaccines Market Overview
1.1 Product Overview and Scope of Measles, Mumps and Rubella (MMR) Vaccines
1.2 Measles, Mumps and Rubella (MMR) Vaccines Segment by Type
1.2.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Monovalent Vaccine
1.2.3 Polyvalent Vaccine
1.3 Measles, Mumps and Rubella (MMR) Vaccines Segment by Application
1.3.1 Measles, Mumps and Rubella (MMR) Vaccines Sales Comparison by Application: 2020 VS 2026
1.3.2 Immune Center
1.3.3 Vaccine Development Agencies and Organizations
1.3.4 Hospital
1.3.5 Laboratory
1.3.6 Biotechnology and Biopharmaceutical Companies
1.4 Global Measles, Mumps and Rubella (MMR) Vaccines Market Size Estimates and Forecasts
1.4.1 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue 2015-2026
1.4.2 Global Measles, Mumps and Rubella (MMR) Vaccines Sales 2015-2026
1.4.3 Measles, Mumps and Rubella (MMR) Vaccines Market Size by Region: 2020 Versus 2026
1.5 Measles, Mumps and Rubella (MMR) Vaccines Industry
1.6 Measles, Mumps and Rubella (MMR) Vaccines Market Trends

2 Global Measles, Mumps and Rubella (MMR) Vaccines Market Competition by Manufacturers
2.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Manufacturers (2015-2020)
2.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Manufacturers (2015-2020)
2.3 Global Measles, Mumps and Rubella (MMR) Vaccines Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Measles, Mumps and Rubella (MMR) Vaccines Manufacturing Sites, Area Served, Product Type
2.5 Measles, Mumps and Rubella (MMR) Vaccines Market Competitive Situation and Trends
2.5.1 Measles, Mumps and Rubella (MMR) Vaccines Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Measles, Mumps and Rubella (MMR) Vaccines Players (Opinion Leaders)

3 Measles, Mumps and Rubella (MMR) Vaccines Retrospective Market Scenario by Region
3.1 Global Measles, Mumps and Rubella (MMR) Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Measles, Mumps and Rubella (MMR) Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures by Country
3.3.1 North America Measles, Mumps and Rubella (MMR) Vaccines Sales by Country
3.3.2 North America Measles, Mumps and Rubella (MMR) Vaccines Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures by Country
3.4.1 Europe Measles, Mumps and Rubella (MMR) Vaccines Sales by Country
3.4.2 Europe Measles, Mumps and Rubella (MMR) Vaccines Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures by Region
3.5.1 Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales by Region
3.5.2 Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures by Country
3.6.1 Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales by Country
3.6.2 Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures by Country
3.7.1 Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales by Country
3.7.2 Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Measles, Mumps and Rubella (MMR) Vaccines Historic Market Analysis by Type
4.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2015-2020)
4.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Type (2015-2020)
4.3 Global Measles, Mumps and Rubella (MMR) Vaccines Price Market Share by Type (2015-2020)
4.4 Global Measles, Mumps and Rubella (MMR) Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Measles, Mumps and Rubella (MMR) Vaccines Historic Market Analysis by Application
5.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2015-2020)
5.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Application (2015-2020)
5.3 Global Measles, Mumps and Rubella (MMR) Vaccines Price by Application (2015-2020)

6 Company Profiles and Key Figures in Measles, Mumps and Rubella (MMR) Vaccines Business
6.1 Medlmmune
6.1.1 Corporation Information
6.1.2 Medlmmune Description, Business Overview and Total Revenue
6.1.3 Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Medlmmune Products Offered
6.1.5 Medlmmune Recent Development
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Corporation Information
6.2.2 Johnson & Johnson Description, Business Overview and Total Revenue
6.2.3 Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Johnson & Johnson Products Offered
6.2.5 Johnson & Johnson Recent Development
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description, Business Overview and Total Revenue
6.3.3 Merck Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Merck Products Offered
6.3.5 Merck Recent Development
6.4 Sanofi
6.4.1 Sanofi Corporation Information
6.4.2 Sanofi Description, Business Overview and Total Revenue
6.4.3 Sanofi Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Sanofi Products Offered
6.4.5 Sanofi Recent Development
6.5 Serum
6.5.1 Serum Corporation Information
6.5.2 Serum Description, Business Overview and Total Revenue
6.5.3 Serum Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Serum Products Offered
6.5.5 Serum Recent Development
6.6 Bavarian Nordic
6.6.1 Bavarian Nordic Corporation Information
6.6.2 Bavarian Nordic Description, Business Overview and Total Revenue
6.6.3 Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Bavarian Nordic Products Offered
6.6.5 Bavarian Nordic Recent Development
6.7 Astellas Pharma
6.6.1 Astellas Pharma Corporation Information
6.6.2 Astellas Pharma Description, Business Overview and Total Revenue
6.6.3 Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Astellas Pharma Products Offered
6.7.5 Astellas Pharma Recent Development
6.8 Emergent BioSolutions
6.8.1 Emergent BioSolutions Corporation Information
6.8.2 Emergent BioSolutions Description, Business Overview and Total Revenue
6.8.3 Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Emergent BioSolutions Products Offered
6.8.5 Emergent BioSolutions Recent Development
6.9 GlaxoSmithKline
6.9.1 GlaxoSmithKline Corporation Information
6.9.2 GlaxoSmithKline Description, Business Overview and Total Revenue
6.9.3 GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.9.4 GlaxoSmithKline Products Offered
6.9.5 GlaxoSmithKline Recent Development
6.10 Pfizer
6.10.1 Pfizer Corporation Information
6.10.2 Pfizer Description, Business Overview and Total Revenue
6.10.3 Pfizer Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Pfizer Products Offered
6.10.5 Pfizer Recent Development
6.11 CSL
6.11.1 CSL Corporation Information
6.11.2 CSL Measles, Mumps and Rubella (MMR) Vaccines Description, Business Overview and Total Revenue
6.11.3 CSL Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.11.4 CSL Products Offered
6.11.5 CSL Recent Development

7 Measles, Mumps and Rubella (MMR) Vaccines Manufacturing Cost Analysis
7.1 Measles, Mumps and Rubella (MMR) Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Measles, Mumps and Rubella (MMR) Vaccines
7.4 Measles, Mumps and Rubella (MMR) Vaccines Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Measles, Mumps and Rubella (MMR) Vaccines Distributors List
8.3 Measles, Mumps and Rubella (MMR) Vaccines Customers

9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis

10 Global Market Forecast
10.1 Global Measles, Mumps and Rubella (MMR) Vaccines Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Measles, Mumps and Rubella (MMR) Vaccines by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Measles, Mumps and Rubella (MMR) Vaccines by Type (2021-2026)
10.2 Measles, Mumps and Rubella (MMR) Vaccines Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Measles, Mumps and Rubella (MMR) Vaccines by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Measles, Mumps and Rubella (MMR) Vaccines by Application (2021-2026)
10.3 Measles, Mumps and Rubella (MMR) Vaccines Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Measles, Mumps and Rubella (MMR) Vaccines by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Measles, Mumps and Rubella (MMR) Vaccines by Region (2021-2026)
10.4 North America Measles, Mumps and Rubella (MMR) Vaccines Estimates and Projections (2021-2026)
10.5 Europe Measles, Mumps and Rubella (MMR) Vaccines Estimates and Projections (2021-2026)
10.6 Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Estimates and Projections (2021-2026)
10.7 Latin America Measles, Mumps and Rubella (MMR) Vaccines Estimates and Projections (2021-2026)
10.8 Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Estimates and Projections (2021-2026)
11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables

Table 1. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) Growth Rate Comparison by Type (2015-2026)

Table 2. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) Comparison by Application: 2020 VS 2026

Table 3. Global Measles, Mumps and Rubella (MMR) Vaccines Market Size by Type (K Doses) (US$ Million) (2020 VS 2026)

Table 4. Global Key Measles, Mumps and Rubella (MMR) Vaccines Manufacturers Covered in This Study

Table 5. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Manufacturers (2015-2020)

Table 6. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Manufacturers (2015-2020)

Table 7. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (Million USD) by Manufacturers (2015-2020)

Table 8. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Manufacturers (2015-2020)

Table 9. Global Market Measles, Mumps and Rubella (MMR) Vaccines Average Price (USD/Dose) of Key Manufacturers (2015-2020)

Table 10. Manufacturers Measles, Mumps and Rubella (MMR) Vaccines Sales Sites and Area Served

Table 11. Manufacturers Measles, Mumps and Rubella (MMR) Vaccines Product Types

Table 12. Global Measles, Mumps and Rubella (MMR) Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 13. Global Measles, Mumps and Rubella (MMR) Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Measles, Mumps and Rubella (MMR) Vaccines as of 2019)

Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 15. Main Points Interviewed from Key Measles, Mumps and Rubella (MMR) Vaccines Players

Table 16. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Region (2015-2020)

Table 17. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Region (2015-2020)

Table 18. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (Million US$) by Region (2015-2020)

Table 19. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Region (2015-2020)

Table 20. North America Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2015-2020) (K Doses)

Table 21. North America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Country (2015-2020)

Table 22. North America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2015-2020) (US$ Million)

Table 23. North America Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Country (2015-2020)

Table 24. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2015-2020) (K Doses)

Table 25. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Country (2015-2020)

Table 26. Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2015-2020) (US$ Million)

Table 27. Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Country (2015-2020)

Table 28. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales by Region (2015-2020) (K Doses)

Table 29. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Region (2015-2020)

Table 30. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue by Region (2015-2020) (US$ Million)

Table 31. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Region (2015-2020)

Table 32. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2015-2020) (K Doses)

Table 33. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Country (2015-2020)

Table 34. Latin America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2015-2020) (US$ Million)

Table 35. Latin America Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Country (2015-2020)

Table 36. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2015-2020) (K Doses)

Table 37. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Country (2015-2020)

Table 38. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2015-2020) (US$ Million)

Table 39. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Country (2015-2020)

Table 40. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Type (2015-2020)

Table 41. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Type (2015-2020)

Table 42. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (Million US$) by Type (2015-2020)

Table 43. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Type (2015-2020)

Table 44. Global Measles, Mumps and Rubella (MMR) Vaccines Price (USD/Dose) by Type (2015-2020)

Table 45. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Application (2015-2020)

Table 46. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2015-2020)

Table 47. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate by Application (2015-2020)

Table 48. Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Corporation Information

Table 49. Medlmmune Description and Business Overview

Table 50. Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

Table 51. Medlmmune Main Product

Table 52. Medlmmune Recent Development

Table 53. Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Corporation Information

Table 54. Johnson & Johnson Corporation Information

Table 55. Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

Table 56. Johnson & Johnson Main Product

Table 57. Johnson & Johnson Recent Development

Table 58. Merck Measles, Mumps and Rubella (MMR) Vaccines Corporation Information

Table 59. Merck Corporation Information

Table 60. Merck Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

Table 61. Merck Main Product

Table 62. Merck Recent Development

Table 63. Sanofi Measles, Mumps and Rubella (MMR) Vaccines Corporation Information

Table 64. Sanofi Corporation Information

Table 65. Sanofi Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

Table 66. Sanofi Main Product

Table 67. Sanofi Recent Development

Table 68. Serum Measles, Mumps and Rubella (MMR) Vaccines Corporation Information

Table 69. Serum Corporation Information

Table 70. Serum Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

Table 71. Serum Main Product

Table 72. Serum Recent Development

Table 73. Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Corporation Information

Table 74. Bavarian Nordic Corporation Information

Table 75. Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

Table 76. Bavarian Nordic Main Product

Table 77. Bavarian Nordic Recent Development

Table 78. Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Corporation Information

Table 79. Astellas Pharma Corporation Information

Table 80. Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

Table 81. Astellas Pharma Main Product

Table 82. Astellas Pharma Recent Development

Table 83. Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Corporation Information

Table 84. Emergent BioSolutions Corporation Information

Table 85. Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

Table 86. Emergent BioSolutions Main Product

Table 87. Emergent BioSolutions Recent Development

Table 88. GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Corporation Information

Table 89. GlaxoSmithKline Corporation Information

Table 90. GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

Table 91. GlaxoSmithKline Main Product

Table 92. GlaxoSmithKline Recent Development

Table 93. Pfizer Measles, Mumps and Rubella (MMR) Vaccines Corporation Information

Table 94. Pfizer Corporation Information

Table 95. Pfizer Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

Table 96. Pfizer Main Product

Table 97. Pfizer Recent Development

Table 98. CSL Measles, Mumps and Rubella (MMR) Vaccines Corporation Information

Table 99. CSL Corporation Information

Table 100. CSL Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

Table 101. CSL Main Product

Table 102. CSL Recent Development

Table 103. Sales Base and Market Concentration Rate of Raw Material

Table 104. Key Suppliers of Raw Materials

Table 105. Measles, Mumps and Rubella (MMR) Vaccines Distributors List

Table 106. Measles, Mumps and Rubella (MMR) Vaccines Customers List

Table 107. Market Key Trends

Table 108. Key Opportunities and Drivers: Impact Analysis (2021-2026)

Table 109. Key Challenges

Table 110. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) Forecast by Type (2021-2026)

Table 111. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share Forecast by Type (2021-2026)

Table 112. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (Million US$) Forecast by Type (2021-2026)

Table 113. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (Million US$) Market Share Forecast by Type (2021-2026)

Table 114. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) Forecast by Application (2021-2026)

Table 115. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (Million US$) Forecast by Application (2021-2026)

Table 116. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) Forecast by Region (2021-2026)

Table 117. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share Forecast by Region (2021-2026)

Table 118. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Forecast by Region (2021-2026) (US$ Million)

Table 119. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share Forecast by Region (2021-2026)

Table 120. Research Programs/Design for This Report

Table 121. Key Data Information from Secondary Sources

Table 122. Key Data Information from Primary Sources

List of Figures

Figure 1. Picture of Measles, Mumps and Rubella (MMR) Vaccines

Figure 2. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type: 2020 VS 2026

Figure 3. Monovalent Vaccine Product Picture

Figure 4. Polyvalent Vaccine Product Picture

Figure 5. Global Measles, Mumps and Rubella (MMR) Vaccines Consumption Market Share by Application: 2020 VS 2026

Figure 6. Immune Center

Figure 7. Vaccine Development Agencies and Organizations

Figure 8. Hospital

Figure 9. Laboratory

Figure 10. Biotechnology and Biopharmaceutical Companies

Figure 11. Global Measles, Mumps and Rubella (MMR) Vaccines Market Size 2015-2026 (US$ Million)

Figure 12. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Capacity (K Doses) (2015-2026)

Figure 13. Global Measles, Mumps and Rubella (MMR) Vaccines Market Size Market Share by Region: 2020 Versus 2026

Figure 14. Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Manufacturers in 2020

Figure 15. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Manufacturers in 2019

Figure 16. The Global 5 and 10 Largest Players: Market Share by Measles, Mumps and Rubella (MMR) Vaccines Revenue in 2019

Figure 17. Measles, Mumps and Rubella (MMR) Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 18. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Region (2015-2020)

Figure 19. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Region in 2019

Figure 20. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Region (2015-2020)

Figure 21. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Region in 2019

Figure 22. North America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Country in 2019

Figure 23. North America Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Country in 2019

Figure 24. U.S. Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses)

Figure 25. U.S. Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

Figure 26. Canada Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses)

Figure 27. Canada Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

Figure 28. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Country in 2019

Figure 29. Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Country in 2019

Figure 30. Germany Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses)

Figure 31. Germany Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

Figure 32. France Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses)

Figure 33. France Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

Figure 34. U.K. Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses)

Figure 35. U.K. Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

Figure 36. Italy Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses)

Figure 37. Italy Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

Figure 38. Russia Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses)

Figure 39. Russia Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

Figure 40. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Region in 2019

Figure 41. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Region in 2019

Figure 42. China Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses)

Figure 43. China Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

Figure 44. Japan Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses)

Figure 45. Japan Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

Figure 46. South Korea Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses)

Figure 47. South Korea Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

Figure 48. India Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses)

Figure 49. India Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

Figure 50. Australia Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses)

Figure 51. Australia Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

Figure 52. Taiwan Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses)

Figure 53. Taiwan Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

Figure 54. Indonesia Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses)

Figure 55. Indonesia Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

Figure 56. Thailand Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses)

Figure 57. Thailand Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

Figure 58. Malaysia Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses)

Figure 59. Malaysia Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

Figure 60. Philippines Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses)

Figure 61. Philippines Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

Figure 62. Vietnam Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses)

Figure 63. Vietnam Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

Figure 64. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Country in 2019

Figure 65. Latin America Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Country in 2019

Figure 66. Mexico Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses)

Figure 67. Mexico Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

Figure 68. Brazil Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses)

Figure 69. Brazil Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

Figure 70. Argentina Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses)

Figure 71. Argentina Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

Figure 72. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Country in 2019

Figure 73. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Country in 2019

Figure 74. Turkey Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses)

Figure 75. Turkey Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

Figure 76. Saudi Arabia Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses)

Figure 77. Saudi Arabia Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

Figure 78. U.A.E Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses)

Figure 79. U.A.E Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

Figure 80. Sales Market Share of Measles, Mumps and Rubella (MMR) Vaccines by Type (2015-2020)

Figure 81. Sales Market Share of Measles, Mumps and Rubella (MMR) Vaccines by Type in 2019

Figure 82. Revenue Share of Measles, Mumps and Rubella (MMR) Vaccines by Type (2015-2020)

Figure 83. Revenue Market Share of Measles, Mumps and Rubella (MMR) Vaccines by Type in 2019

Figure 84. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Growth by Type (2015-2020) (K Doses)

Figure 85. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2015-2020)

Figure 86. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application in 2019

Figure 87. Global Revenue Share of Measles, Mumps and Rubella (MMR) Vaccines by Application (2015-2020)

Figure 88. Global Revenue Share of Measles, Mumps and Rubella (MMR) Vaccines by Application in 2020

Figure 89. Medlmmune Total Revenue (US$ Million): 2019 Compared with 2018

Figure 90. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018

Figure 91. Merck Total Revenue (US$ Million): 2019 Compared with 2018

Figure 92. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018

Figure 93. Serum Total Revenue (US$ Million): 2019 Compared with 2018

Figure 94. Bavarian Nordic Total Revenue (US$ Million): 2019 Compared with 2018

Figure 95. Astellas Pharma Total Revenue (US$ Million): 2019 Compared with 2018

Figure 96. Emergent BioSolutions Total Revenue (US$ Million): 2019 Compared with 2018

Figure 97. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018

Figure 98. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018

Figure 99. CSL Total Revenue (US$ Million): 2019 Compared with 2018

Figure 100. Price Trend of Key Raw Materials

Figure 101. Manufacturing Cost Structure of Measles, Mumps and Rubella (MMR) Vaccines

Figure 102. Manufacturing Process Analysis of Measles, Mumps and Rubella (MMR) Vaccines

Figure 103. Measles, Mumps and Rubella (MMR) Vaccines Industrial Chain Analysis

Figure 104. Channels of Distribution

Figure 105. Distributors Profiles

Figure 106. Porter's Five Forces Analysis

Figure 107. North America Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) and Growth Rate Forecast (2021-2026)

Figure 108. North America Measles, Mumps and Rubella (MMR) Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 109. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) and Growth Rate Forecast (2021-2026)

Figure 110. Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 111. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) and Growth Rate Forecast (2021-2026)

Figure 112. Latin America Measles, Mumps and Rubella (MMR) Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 113. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) and Growth Rate Forecast (2021-2026)

Figure 114. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 115. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) and Growth Rate Forecast (2021-2026)

Figure 116. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 117. Bottom-up and Top-down Approaches for This Report

Figure 118. Data Triangulation

Figure 119. Key Executives Interviewed

Medlmmune

Johnson & Johnson

Merck

Sanofi

Serum

Bavarian Nordic

Astellas Pharma

Emergent BioSolutions

GlaxoSmithKline

Pfizer

CSL

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $2175

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase